Clinical Trial Update: Intravenous Milk Thistle (Silibinin-Legalon) for Hepatic Failure Induced by Amatoxin/Amanita Mushroom Poisoning [Phase 2]

View source ↗

Summary

Phase 2 trial of intravenous silibinin-legalon for hepatic failure due to amatoxin/Amita mushroom poisoning was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amanita Poisoning
• Amatoxin Poisoning
• Liver Failure
• Mushroom Poisoning

Drugs mentioned

• intravenous silibinin-legalon (silibinin)

Snippet

Sponsor: Mylan Specialty, LP | Conditions: Amatoxin Poisoning, Amanita Poisoning | Phase 2 | Status: TERMINATED | Results posted: 2022-04-07